Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




PerkinElmer

click to enlarge

Compliance Software

NexION® Enhanced Security™ (ES) software is designed to streamline regulatory compliance by pharmaceutical companies. The ES Software platform was developed for users of the NexION 300 ICP-MS system. The NexION ES software platform ensures the integrity of electronic data records that are generated under industry-standard protocols within pharma research and QA/QC organizations. It was designed to enable researchers and quality control professionals to meet FDA 21 CFR Part 11 regulations through key compliance-centric features. The NexION ES Software provides user level management, file protection, and audit trails. The system provides technical compliance in terms of software development and data integrity, with security features that help create a secure, reliable environment.

  • PerkinElmer
  • 940 Winter Street
  • Waltham, MA, 02451
  • UNITED STATES

Related To This Company

Products

Advertisements

Related content

Webinars

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Funding Early-Stage Companies

How much do you think newly established funds will succeed in helping startups?

Suggest a Poll